The effects of octreotide, a synthetic somatostatin analogue, were examined
in 43 Japanese patients with pylorus-preserving pancreatoduodenectomy. The
43 patients were divided into two groups: 13 patients to whom a daily dose
of 100 mu g of octreotide was administered continuously and subcutaneously
for the first 10 postoperative days (octreotide group); and 30 patients to
whom octreotide was not administered (control group). Within 10 postoperat
ive days, pancreatoenterostomy leakage was evident in one (7.7%) of the 13
patients in the octreotide group, but in five (16.7%) of the 30 patients in
the control group. The total amount of the pancreatic juice drained extern
ally during the first 10 postoperative days was 848 +/- 200 ml in the octre
otide group and 1152 +/- 180 ml in the control group. When limited to 20 pa
tients who underwent pancreatoenterostomy with total tube drainage, the amo
unt of pancreatic juice in 10 patients in the octreotide group examined was
796 +/- 232 ml, which was significantly lower than the 1690 +/- 334 ml in
10 patients in the control group examined (P < 0.05). Of the 10 patients in
the octreotide group, the amount of pancreatic juice during postoperative
days 6-10 when octreotide was given was reduced to 382 +/- 104 ml compared
to 445 +/- 108 ml during postoperative days 11-15 when octreotide was not a
dministered (P < 0.05). These findings suggest that subcutaneous injection
of octreotide, 100 mu g per day during the first 10 postoperative days, inh
ibits pancreatic exocrine secretion and decreases pancreatoenterostomy leak
age.